Our mission is to provide easy and accessible diagnostic testing through minimally-invasive dermal interstitial fluid (ISF) collection, removing the barriers of painful blood draws for biomarker analysis.

With further funding, we plan to expand our lab, grow our engineering team, and collaborate with both government and business sectors. DermiSense envisions a future where diagnostics are quick, affordable, and pain-free, benefiting people in remote areas and those with a fear of needles, while significantly cutting healthcare costs.